467 related articles for article (PubMed ID: 32372339)
1. Design, synthesis, and evaluation of novel cinnamic acid-tryptamine hybrid for inhibition of acetylcholinesterase and butyrylcholinesterase.
Ghafary S; Ghobadian R; Mahdavi M; Nadri H; Moradi A; Akbarzadeh T; Najafi Z; Sharifzadeh M; Edraki N; Moghadam FH; Amini M
Daru; 2020 Dec; 28(2):463-477. PubMed ID: 32372339
[TBL] [Abstract][Full Text] [Related]
2. Novel cinnamic acid-tryptamine hybrids as potent butyrylcholinesterase inhibitors: Synthesis, biological evaluation, and docking study.
Ghafary S; Najafi Z; Mohammadi-Khanaposhtani M; Nadri H; Edraki N; Ayashi N; Larijani B; Amini M; Mahdavi M
Arch Pharm (Weinheim); 2018 Oct; 351(10):e1800115. PubMed ID: 30284339
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis, and Evaluation of Acetylcholinesterase and Butyrylcholinesterase Dual-Target Inhibitors against Alzheimer's Diseases.
Guo Y; Yang H; Huang Z; Tian S; Li Q; Du C; Chen T; Liu Y; Sun H; Liu Z
Molecules; 2020 Jan; 25(3):. PubMed ID: 31979317
[TBL] [Abstract][Full Text] [Related]
4. Design and Synthesis of Selective Acetylcholinesterase Inhibitors: Arylisoxazole-Phenylpiperazine Derivatives.
Saeedi M; Mohtadi-Haghighi D; Mirfazli SS; Mahdavi M; Hariri R; Lotfian H; Edraki N; Iraji A; Firuzi O; Akbarzadeh T
Chem Biodivers; 2019 Feb; 16(2):e1800433. PubMed ID: 30460743
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, biological evaluation, and docking study of novel dual-acting thiazole-pyridiniums inhibiting acetylcholinesterase and β-amyloid aggregation for Alzheimer's disease.
Ghotbi G; Mahdavi M; Najafi Z; Moghadam FH; Hamzeh-Mivehroud M; Davaran S; Dastmalchi S
Bioorg Chem; 2020 Oct; 103():104186. PubMed ID: 32890993
[TBL] [Abstract][Full Text] [Related]
6. Novel N-benzylpyridinium moiety linked to arylisoxazole derivatives as selective butyrylcholinesterase inhibitors: Synthesis, biological evaluation, and docking study.
Vafadarnejad F; Karimpour-Razkenari E; Sameem B; Saeedi M; Firuzi O; Edraki N; Mahdavi M; Akbarzadeh T
Bioorg Chem; 2019 Nov; 92():103192. PubMed ID: 31446239
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity study of fluorine or chlorine-substituted cinnamic acid derivatives with tertiary amine side chain in acetylcholinesterase and butyrylcholinesterase inhibition.
Gao XH; Tang JJ; Liu HR; Liu LB; Liu YZ
Drug Dev Res; 2019 Jun; 80(4):438-445. PubMed ID: 30680760
[TBL] [Abstract][Full Text] [Related]
8. Novel tacrine-based acetylcholinesterase inhibitors as potential agents for the treatment of Alzheimer's disease: Quinolotacrine hybrids.
Sadafi Kohnehshahri M; Chehardoli G; Bahiraei M; Akbarzadeh T; Ranjbar A; Rastegari A; Najafi Z
Mol Divers; 2022 Feb; 26(1):489-503. PubMed ID: 34491490
[TBL] [Abstract][Full Text] [Related]
9. Development of quinazolinone and vanillin acrylamide hybrids as multi-target directed ligands against Alzheimer's disease and mechanistic insights into their binding with acetylcholinesterase.
Yelamanda Rao K; Jeelan Basha S; Monika K; Naidu Gajula N; Sivakumar I; Kumar S; Vadde R; Aramati BMR; Subramanyam R; Damu AG
J Biomol Struct Dyn; 2023 Dec; 41(20):11148-11165. PubMed ID: 37098803
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological evaluation of carbamate derivatives of N-salicyloyl tryptamine as multifunctional agents for the treatment of Alzheimer's disease.
Liu D; Zhang H; Wang Y; Liu W; Yin G; Wang D; Li J; Shi T; Wang Z
Eur J Med Chem; 2022 Feb; 229():114044. PubMed ID: 34923430
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and evaluation of novel 4-dimethylamine flavonoid derivatives as potential multi-functional anti-Alzheimer agents.
Luo W; Su YB; Hong C; Tian RG; Su LP; Wang YQ; Li Y; Yue JJ; Wang CJ
Bioorg Med Chem; 2013 Dec; 21(23):7275-82. PubMed ID: 24148835
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological activity of novel donepezil derivatives bearing N-benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors.
Lan JS; Zhang T; Liu Y; Yang J; Xie SS; Liu J; Miao ZY; Ding Y
Eur J Med Chem; 2017 Jun; 133():184-196. PubMed ID: 28388521
[TBL] [Abstract][Full Text] [Related]
13. Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors:
Makhaeva GF; Kovaleva NV; Boltneva NP; Rudakova EV; Lushchekina SV; Astakhova TY; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Korabecny J; Soukup O; Bachurin SO; Richardson RJ
Molecules; 2022 Feb; 27(3):. PubMed ID: 35164325
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, biological evaluation, and molecular modeling studies of quinoline-ferulic acid hybrids as cholinesterase inhibitors.
Mo J; Yang H; Chen T; Li Q; Lin H; Feng F; Liu W; Qu W; Guo Q; Chi H; Chen Y; Sun H
Bioorg Chem; 2019 Dec; 93():103310. PubMed ID: 31586704
[TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis and Investigation of New Diphenyl Substituted Pyridazinone Derivatives as Both Cholinesterase and Aβ-Aggregation Inhibitors.
Kilic B; Erdogan M; Gulcan HO; Aksakal F; Oruklu N; Bagriacik EU; Dogruer DS
Med Chem; 2019; 15(1):59-76. PubMed ID: 29792155
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, biological activity and molecular modeling studies on 1H-benzimidazole derivatives as acetylcholinesterase inhibitors.
Alpan AS; Parlar S; Carlino L; Tarikogullari AH; Alptüzün V; Güneş HS
Bioorg Med Chem; 2013 Sep; 21(17):4928-37. PubMed ID: 23891231
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of some new carboxamide and propanamide derivatives bearing phenylpyridazine as a core ring and the investigation of their inhibitory potential on in-vitro acetylcholinesterase and butyrylcholinesterase.
Kilic B; Gulcan HO; Aksakal F; Ercetin T; Oruklu N; Umit Bagriacik E; Dogruer DS
Bioorg Chem; 2018 Sep; 79():235-249. PubMed ID: 29775949
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationship investigation of tertiary amine derivatives of cinnamic acid as acetylcholinesterase and butyrylcholinesterase inhibitors: compared with that of phenylpropionic acid, sorbic acid and hexanoic acid.
Gao X; Tang J; Liu H; Liu L; Kang L; Chen W
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):519-524. PubMed ID: 29447012
[TBL] [Abstract][Full Text] [Related]
20. Discovery of New Selective Butyrylcholinesterase (BChE) Inhibitors with Anti-Aβ Aggregation Activity: Structure-Based Virtual Screening, Hit Optimization and Biological Evaluation.
Jiang CS; Ge YX; Cheng ZQ; Wang YY; Tao HR; Zhu K; Zhang H
Molecules; 2019 Jul; 24(14):. PubMed ID: 31311169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]